Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding
Others
Ratios

NewAmsterdam Pharma (NAMSW) Other Operating Expenses (2025)

Historic Other Operating Expenses for NewAmsterdam Pharma (NAMSW) over the last 1 years, with Q3 2025 value amounting to -$1000.0.

  • NewAmsterdam Pharma's Other Operating Expenses changed N/A to -$1000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1000.0, marking a year-over-year change of. This contributed to the annual value of $61.8 million for FY2022, which is N/A changed from last year.
  • NewAmsterdam Pharma's Other Operating Expenses amounted to -$1000.0 in Q3 2025.
  • Over the past 5 years, NewAmsterdam Pharma's Other Operating Expenses peaked at -$1000.0 during Q3 2025, and registered a low of -$1000.0 during Q3 2025.